The primary objective of this trial is to evaluate the safety and efficacy of treatment with
anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the
Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism
(PE).